Ondine Biomedical (FRA:VF5) Pretax Margin %: -952.26% (As of Dec. 2024)


FRA:VF5 Ondine Biomedical Inc FRA:VF5
47 GF Score
Price €0.20
View Full Analysis

What is Ondine Biomedical Pretax Margin %?

Ondine Biomedical FRA:VF5 +30.00% 47 Pretax Margin % is -952.26% as of Dec. 2024. GuruFocus rates FRA:VF5 with a GF Score™ of 47/100.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Ondine Biomedical's Pre-Tax Income for the six months ended in Dec. 2024 was €-7.60 Mil. Ondine Biomedical's Revenue for the six months ended in Dec. 2024 was €0.80 Mil. Therefore, Ondine Biomedical's pretax margin for the quarter that ended in Dec. 2024 was -952.26%.

The historical rank and industry rank for Ondine Biomedical's Pretax Margin % or its related term are showing as below:


FRA:VF5's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -90.5
* Ranked among companies with meaningful Pretax Margin % only.

Ondine Biomedical  (FRA:VF5) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Ondine Biomedical Pretax Margin % Related Terms

Ondine Biomedical Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Ondine Biomedical's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ondine Biomedical Pretax Margin % Chart

Ondine Biomedical Annual Data
Trend Dec09 Dec10 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -908.79 -1,949.83 -3,038.60 -1,198.42 -932.41

Ondine Biomedical Semi-Annual Data
Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,875.86 -1,847.81 -839.81 -904.12 -952.26

FRA:VF5 vs VRTX, REGN, ALNY: Pretax Margin % Comparison

For the Biotechnology subindustry, Ondine Biomedical's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ondine Biomedical Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ondine Biomedical's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Ondine Biomedical's Pretax Margin % falls into.


FRA:VF5
47GF Score
Ondine Biomedical Inc FRA:VF5
Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ondine Biomedical Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Ondine Biomedical's Pretax Margin for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-12.802/1.373
=-932.41 %

Ondine Biomedical's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-7.599/0.798
=-952.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of -952.26% mean?
Ondine Biomedical (FRA:VF5) has a Pretax Margin % of -952.26% as of Dec. 2024. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Ondine Biomedical and its competitors.
Is Ondine Biomedical's Pretax Margin % too high?
Ondine Biomedical's current Pretax Margin % is -952.26%. Overall, Ondine Biomedical has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Ondine Biomedical's Pretax Margin % compare to VRTX and REGN?
Ondine Biomedical's Pretax Margin % of -952.26% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Ondine Biomedical and its competitors. Ondine Biomedical's current Pretax Margin % is -952.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ondine Biomedical stock overvalued right now?
Ondine Biomedical (FRA:VF5) has a current Pretax Margin % of -952.26%. The current Pretax Margin % is -952.26%. Ondine Biomedical's overall GF Score™ is 47/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Ondine Biomedical (FRA:VF5), the current Pretax Margin % is -952.26% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ondine Biomedical Business Description

Address 1100 Melville Street, Suite 888, Vancouver, BC, CAN, V6E4A6
Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.
47GF Score

Get the complete analysis for FRA:VF5

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.20
Price